Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women

Journal of Hypertension

Volumn 21, Issue 12, 2003, Pages 2275-2280

  Virdis, Agostino ^a   Pinto, Stefania ^a   Versari, Daniele ^a   Salvetti, Guido ^a   Bernini, Gianpaolo ^a   Fruzzetti, Franca ^a   Genazzani, Andrea R ^a   Taddei, Stefano ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Endothelium; Nitric oxide; Oral contraceptives; Oxidative stress

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ASCORBIC ACID; ETHINYLESTRADIOL PLUS GESTODENE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MICROCIRCULATION; OXIDATIVE STRESS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 1442299081     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200312000-00015     Document Type: Article

References (29)

1. Taddei S, Salvetti A. Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002; 20:1671-1674.
2. Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948-954.
3. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
4. Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86:207-210.
5. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104:2673-2678.
6. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med 1981; 305:672-677.
7. Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 343:1787-1793.
8. Thorogood M, Vessey PM. An epidemiological survey of cardiovascular disease in women taking oral contraceptives. Am J Obstet Gynecol 1990; 163:274-281.
9. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international case-control study. Lancet 1997; 349:1202-1209.
10. Lewis MA, Spitzer WO, Heinemann LAJ, MacRae KD, Bruppacher R, Thorogood M, on behalf of Trans-National Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. BMJ 1996; 312:88-90.
11. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene. Analysis of the transcriptional factors involved. Hypertension 1998; 31:582-588.
12. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 93:4108-4113.
13. Glusa E, Gräser T, Wagner S, Oettel M. Mechanism of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 1997; 28:181-191.
14. Jiang G, Sarel PM, Lindsay DC, Poole-Wilson PA, Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary arteries in vitro. Eur J Pharmacol 1992; 211:163-167.
15. Sorensen MB, Collins P, Ong PJL, Webb CM, Hayward CS, Asbury EA, et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002; 106:1646-1651.
16. Lobo RA, Pickar JH, Wild RA, Walsh BW, Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 1994; 84:173-179.
17. Merki-Feld GS, Rosselli M, Dubey RK, Jager AW, Keller PJ. Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women. Contraception 2002; 65:231-236.
18. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97:2222-2229.
19. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96:418-424.
20. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocyst(e)inemia in normotensive subjects and essential hypertensive patients. J Am Coll Cardiol 2001; 38:1106-1115.
21. Bendich A, Machlin IJ, Scandurra O, Burton GW, Wayner DDM. The antioxidant role of vitamin C. Adv Free Radic Biol Med 1986; 2: 419-444.
22. John S, Jacobi J, Schlaich MP, Delles C, Schmieder RE, et al. Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol 2000; 183:28-33.
23. Ting HH, Timini FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95:2617-2622.
24. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini GP, Magagna A, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001; 38:274-279.
25. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88:2541-2547.
26. Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, et al. Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles. Cardiovasc Res 2001; 50:577-582.
27. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997; 95:76-82.
28. Spieker LE, Sudano I, Hurlimann D, Lerch PG, Lang MG, Binggeli C, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105:1399-1402.
29. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, et al. Endothelial function and common carotid wall thickening in essential hypertensive patients. Hypertension 1998; 32:25-32.